Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2001
10/10/2001EP1142879A1 Imidazole compounds and medicinal use thereof
10/10/2001EP1142877A1 2-oxoquinoline compounds and medicinal uses thereof
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1141153A1 Crosslinking agent for carboxyl-containing polymers in heat-curable systems
10/10/2001EP1140944A1 Epothilone derivatives and their use as antitumor agents
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140917A1 S-oxide lipid lowering compounds
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140915A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140911A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140910A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140909A1 Novel inhibitors of farnesyl-protein transferase
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140905A1 Heteroaromatic amides as inhibitor of factor xa
10/10/2001EP1140904A1 Farnesyl protein transferase inhibitors
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
10/10/2001EP1140890A1 Chroman derivatives
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140845A1 Susbstituted pyridine herbicides
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140820A1 New amidino derivatives and their use as thrombin inhibitors
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1140074A1 Indole and indolizidine derivatives for the treatment of migraine
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001EP0759907B1 Substituted 3-phenylpyrazoles for use as herbicides
10/10/2001CN1317002A Oxygenic heterocyclic compounds
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316425A Photochromic diarylheterocycloethylene compounds sensitive to blue light and its preparing process and usage
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072668C Dihydrobenzofuran and related compounds useful and anti-inflammatory agents
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300503 Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300359 (E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt
10/09/2001US6300333 Substituted piperidines, processes for their preparation and their use as pesticides and fungicides
10/09/2001US6300330 Blood coagulation factor x inhibitors as anticoagulants
10/09/2001US6300316 C-4 substituted macrolide antibiotics
10/09/2001CA2218306C Method of preventing allograft rejection
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/09/2001CA2177147C 2-oxoindoline derivative
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072742A1 Bisamidino compounds as nhe-3 inhibitors
10/04/2001WO2001072741A2 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072735A2 Benzopyranes useful as tnf alpha inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072706A1 Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001046144A8 New modulators of dopamine neurotransmission
10/04/2001WO2001029245A8 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027195 Indeno [1,2-c]pyrazol-4-ones and their uses
10/04/2001EP1138685A2 Process for preparing substituted pyridines
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137737A1 Liquid crystal compound
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137646A1 Derivative of paroxetine
10/04/2001EP1137645A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
10/04/2001EP1137644A1 Benzofuran derivatives, their preparation and use
10/04/2001EP1137636A1 Process for preparation of paroxetine maleate
1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 694